Dendrimer nanoparticles for ocular drug delivery

Research output: Contribution to journalReview articlepeer-review


Eye is a unique organ of perfection and complexity, and is a microcosm of the body in many ways. It represents a great opportunity for nanomedicine, since it is readily accessible - allowing for direct drug/gene delivery to maximize the therapeutic effect and minimize side effects. The development of appropriate delivery systems that can sustain and deliver therapeutics to the target tissues is a key challenge that can be addressed by nanotechnology. Dendrimers are tree-like, nanostructured polymers that have received significant attention as ocular drug delivery systems, due to their well-defined size, tailorable structure, and potentially favorable ocular biodistribution. In this review, we highlight recent developments in dendrimer-based ocular therapies for both anterior and posterior segment diseases.

Original languageEnglish (US)
Pages (from-to)151-165
Number of pages15
JournalJournal of Ocular Pharmacology and Therapeutics
Issue number2
StatePublished - Mar 1 2013

ASJC Scopus subject areas

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Dendrimer nanoparticles for ocular drug delivery'. Together they form a unique fingerprint.

Cite this